Market Tracker

12/22 6:05pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
10.82 -0.22 / -1.99%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
10.82 0.00 / 0.00%
 
Volume: 19.2K

Today’s Trading

Previous close11.04
Today’s open11.03
Day’s range10.56 - 11.07
Volume1,351,083
Average volume (3 months)2,489,772
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 12/22/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+32.83%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...+1.09+2.91%
NLNKNewLink Genetics Cor...-0.21-0.52%
PDLIPDL BioPharma Inc0.000.00%
KPTIKaryopharm Therapeut...+0.54+1.40%
Data as of 4:00pm ET, 12/22/2014

Financials

Next reporting dateMarch 12, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts